60 Plus Association
The 60 Plus Association describes itself as a "non-partisan seniors advocacy group with a free enterprise, less government, less taxes approach." They list their main issues as the "death tax" (estate tax), energy, health care and Social Security.  60 Plus is registered as a 501(c)(4) non-profit with the Internal Revenue Service. 
However, a 2006 report in the AARP Bulletin called 60 Plus a front group for the pharmaceutical industry. 60 Plus, along with Senior Coalition and United Seniors Association, "claim to speak for millions of older Americans, although as recently as 2001 none of the three listed any revenue from membership dues on their tax returns." The article added: "virtually all of their largest contributions in recent years have come from the same source -- the nation's pharmaceutical industry." 
The 60 Plus Association has championed the pharmaceutical industry in mass mailings, press releases, lobbying and law suits since its inception. It was one of three associations that backed the "astroturf" issue ads of Citizens for Better Medicare (a drug industry front group) during the 2000 elections.
Around the same time, 60 Plus fought state legislation dealing with prescription drugs. The group fought "such legislation in Minnesota and New Mexico," with assistance from the Bonner & Associates firm, which specializes in astroturf lobbying. "The firm's paid callers, reading from scripts that identified them as representatives of 60 Plus, urged residents to ask their governors to veto the legislation. Pharmaceutical giant Pfizer Inc. later said it had paid Bonner & Associates to make the calls," reported AARP.
"In its 2001 fiscal year, 60 Plus got a total of $275,000 from PhRMA (the Pharmaceutical Research and Manufacturers of America), CBM (Citizens for Better Medicare) and three drug companies (Merck, Pfizer and Wyeth-Ayerst) plus another $300,000 from Hanwha International Corp., the U.S. subsidiary of a Korean conglomerate with chemical and pharmaceutical interests -- amounts that made up about 29 percent of its revenue," reported AARP.
60 Plus supported a lawsuit by Pharmaceutical Research and Manufacturers of America against the state of Maine (in a "friend of the court" brief) for daring to try to pass a law that will authentically reduce prices for Medicare drugs by allowing the state to buy in bulk directly from manufacturers. It has also joined a lawsuit against the Federal Communications Commission regarding campaign reform (specifically in support of soft money for issue ads).
In the 2002 election campaigns, 60 Plus paid for issue ads on local radio and TV stations across the country saying that local Republican candidates "care for seniors" so much that they "passed a prescription drug bill" that "saved us from an inept government bureaucracy meddling with health plan benefits."